Dudediligence.

Becton, Dickinson and Company

BDXNYSE · Surgical & Medical Instruments & Apparatus
Write an idea

Insiders

Last 12 months

Sales planned on beside the trades reported on , and whether each names a .

Planned ·

$8,060,855

26 notices · 44,857 sh

Oct 2025 to Oct 2026

Reported ·

$1,343,307

15 sales · 0 buys

Oct 2025 to Jun 2026

The two figures cover different periods.

13 of 15 reported sales carry the 10b5-1 box. Together they are under 0.01% of the shares on issue.

PLANNED · FORM 144Oct 2025 to Oct 2026REPORTED · FORM 4Oct 2025 to Jun 2026N2025DJ2026FMAMJJASO2026-09-28: MICHAEL FELD, Form 1442026-08-26: MICHAEL FELD, Form 1442026-08-20: RICHARD BYRD, Form 1442026-08-13: THOMAS POLEN, Form 1442026-08-11: Roland Goette, Form 1442026-08-03: SHANA NEAL, Form 1442026-07-27: MICHAEL FELD, Form 1442026-06-26: MICHAEL FELD, Form 1442026-06-24: MICHAEL GARRISON, Form 1442026-06-10: MICHAEL GARRISON, Form 1442026-06-01: THOMAS POLEN, Form 1442026-05-26: MICHAEL FELD, Form 1442026-04-27: MICHAEL FELD, Form 1442026-03-26: MICHAEL FELD, Form 1442026-02-26: MICHAEL FELD, Form 1442026-02-20: DAVID MICHEL SHAN, Form 1442026-02-20: CHRISTOPHER DELOREFICE, Form 1442026-02-18: CHRISTOPHER DELOREFICE, Form 1442026-02-18: BERTRAM SCOTT, Form 1442026-01-26: MICHAEL FELD, Form 1442026-01-15: MICHAEL GARRISON, Form 1442025-12-26: MICHAEL FELD, Form 1442025-12-17: MICHAEL GARRISON, Form 1442025-12-01: MICHAEL FELD, Form 1442025-11-07: BERTRAM SCOTT, Form 1442025-10-27: MICHAEL FELD, Form 1442025-10-27: Feld Michael, sold2025-11-07: SCOTT BERTRAM L, sold2025-12-01: Feld Michael, sold2025-12-17: Garrison Michael David, sold2025-12-26: Feld Michael, sold2026-01-15: Garrison Michael David, sold2026-01-26: Feld Michael, sold2026-02-18: SCOTT BERTRAM L, sold2026-02-26: Feld Michael, sold2026-03-26: Feld Michael, sold2026-04-27: Feld Michael, sold2026-05-26: Feld Michael, sold2026-06-01: Polen Thomas E Jr, sold2026-06-10: Garrison Michael David, sold
under a no plan named▼ salesize is dollars

Form 144 notices, newest first

2026-09-28MICHAEL FELD, EVP, Chief Revenue Officer$13,970
76 shplan 2026-05-27Form 4s on file end Jun 23144 ↗
2026-08-26MICHAEL FELD, EVP, Chief Revenue Officer$31,314
165 shplan 2026-05-27Form 4s on file end Jun 23144 ↗
2026-08-20RICHARD BYRD, EVP & President Interventional$249,993
1,330 shno plan dateForm 4s on file end Jun 23144 ↗
2026-08-13THOMAS POLEN, Chairman, CEO and President$762,224
4,152 shplan 2026-03-02Form 4s on file end Jun 23144 ↗
2026-08-11Roland Goette, EVP and President, EMEA$440,877
2,438 shno plan dateForm 4s on file end Jun 23144 ↗
2026-08-03SHANA NEAL, EVP and Chief People Officer$248,430
1,500 shplan 2026-02-27Form 4s on file end Jun 23144 ↗
2026-07-27MICHAEL FELD, EVP, Chief Revenue Officer$11,727
75 shplan 2025-02-07Form 4s on file end Jun 23144 ↗
2026-06-26MICHAEL FELD, EVP, Chief Revenue Officer$11,354
75 shplan 2025-02-07144 ↗
Form 4, 2026-06-26: sold 75 at $152.80 Form 4 ↗
2026-06-24MICHAEL GARRISON, EVP & Pres Med.Essntl&BioPharm$158,312
1,100 shplan 2026-02-18144 ↗
Form 4, 2026-06-25: sold 1,100 at $145.66 Form 4 ↗
2026-06-10MICHAEL GARRISON, EVP & Pres Med.Essntl&BioPharm$167,244
1,100 shplan 2026-02-18144 ↗
Form 4, 2026-06-11: sold 1,100 at $151.48 Form 4 ↗
2026-06-01THOMAS POLEN, Chairman, CEO and President$406,640
2,764 shplan 2026-03-02144 ↗
Form 4, 2026-06-03: sold 2,764 at $146.35 Form 4 ↗
2026-05-26MICHAEL FELD, EVP, Chief Revenue Officer$11,072
75 shplan 2025-02-07144 ↗
Form 4, 2026-05-27: sold 75 at $147.35 Form 4 ↗
2026-04-27MICHAEL FELD, EVP, Chief Revenue Officer$11,258
74 shplan 2025-02-07144 ↗
Form 4, 2026-04-28: sold 74 at $151.94 Form 4 ↗
2026-03-26MICHAEL FELD, EVP, Chief Revenue Officer$11,870
75 shplan 2025-02-07144 ↗
Form 4, 2026-03-27: sold 75 at $156.83 Form 4 ↗
2026-02-26MICHAEL FELD, EVP, Chief Revenue Officer$13,572
75 shplan 2025-02-07144 ↗
Form 4, 2026-02-27: sold 75 at $181.84 Form 4 ↗
2026-02-20DAVID MICHEL SHAN, EVP and Chief ISC Officer$998,429
5,422 shno plan dateno Form 4 on file144 ↗
2026-02-20CHRISTOPHER DELOREFICE, EVP & Chief Financial Officer$2,079,070
11,305 shno plan dateno Form 4 on file144 ↗
2026-02-18CHRISTOPHER DELOREFICE, EVP & Chief Financial Officer$1,708,886
9,366 shno plan dateno Form 4 on file144 ↗
2026-02-18BERTRAM SCOTT, Director$174,027
953 shno plan date144 ↗
Form 4, 2026-02-18: sold 953 at $182.61 Form 4 ↗
2026-01-26MICHAEL FELD, EVP, Chief Revenue Officer$15,134
75 shplan 2025-02-07144 ↗
Form 4, 2026-01-28: sold 75 at $202.73 Form 4 ↗
2026-01-15MICHAEL GARRISON, EVP & Pres Med.Essntl&BioPharm$333,946
1,610 shplan 2025-08-13144 ↗
Form 4, 2026-01-16: sold 1,610 at $207.46 Form 4 ↗
2025-12-26MICHAEL FELD, EVP, Chief Revenue Officer$14,513
74 shplan 2025-02-07144 ↗
Form 4, 2025-12-29: sold 74 at $196.08 Form 4 ↗
2025-12-17MICHAEL GARRISON, EVP & Pres Med.Essntl&BioPharm$123,529
629 shplan 2025-08-13144 ↗
Form 4, 2025-12-17: sold 629 at $196.03 Form 4 ↗
2025-12-01MICHAEL FELD, EVP, Chief Revenue Officer$14,552
75 shplan 2025-02-07144 ↗
Form 4, 2025-12-02: sold 75 at $193.36 Form 4 ↗
2025-11-07BERTRAM SCOTT, Officer$38,318
217 shno plan date144 ↗
Form 4, 2025-11-07: sold 217 at $176.58 Form 4 ↗
2025-10-27MICHAEL FELD, EVP, Chief Revenue Officer$10,592
57 shplan 2025-02-07144 ↗
Form 4, 2025-10-28: sold 57 at $186.01 Form 4 ↗